• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对经典型霍奇金淋巴瘤患病率及临床病理特征的十年洞察:来自印度尼西亚一家三级医院的研究

A Decade of Prevalence and Clinicopathological Insights Into Classical Hodgkin Lymphoma: A Study From an Indonesian Tertiary Hospital.

作者信息

Harahap Agnes S, Charles Stefanny, Ham Maria F

机构信息

Anatomical Pathology Department, Faculty of Medicine, Dr. Cipto Mangunkusumo/Universitas Indonesia, Jakarta, IDN.

Human Cancer Research Center, Indonesian Medical Education and Research Institute, Jakarta, IDN.

出版信息

Cureus. 2024 Nov 11;16(11):e73482. doi: 10.7759/cureus.73482. eCollection 2024 Nov.

DOI:10.7759/cureus.73482
PMID:39669843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11634568/
Abstract

Background Classical Hodgkin lymphoma (cHL) is a lymphoid malignancy originating from germinal center B cells, predominantly affecting young adults. The clinical profile, histologic subtypes, and immunohistochemical (IHC) patterns play crucial roles in diagnosing cHL and predicting prognosis. This study examines the prevalence, clinicopathological features, and IHC patterns of cHL at Dr. Cipto Mangunkusumo Hospital in Jakarta, Indonesia, based on large-scale data collected over a decade. Methods This retrospective analysis included 739 confirmed cases of cHL from 2014 to 2023, identified using hematoxylin and eosin staining and an IHC panel. Data on patient demographics, tumor locations, and stages were collected from medical records. The IHC markers utilized were CD20, CD3, CD30, CD15, PAX5, MUM1, Ki67, and CD45. Chi-square and Fisher exact tests were employed to analyze the distribution of subtypes across different age groups and stages. Result The most affected age group was 20-29 years, comprising 239 cases (32.34%), with a male predominance of 396 cases (53.59%). The majority of tumors were located in nodal areas, accounting for 532 cases (84.31%), while 99 cases (15.69%) were found in extranodal sites, predominantly in the mediastinum. The nodular sclerosis (NS) subtype was the most frequent, accounting for 461 cases (62.38%), followed by mixed cellularity, lymphocyte-depleted, and lymphocyte-rich classical Hodgkin lymphoma. Most cases were diagnosed at early stages (I-III), with NS significantly associated with early-stage diagnosis (OR 3.06, 95% confidence interval (CI) 1.30-7.22). Conclusion The occurrence of HL in terms of prevalence, age, gender, and stage in our study is similar to other Asian countries. Notable correlations were observed between HL subtypes with age and stage.

摘要

背景 经典型霍奇金淋巴瘤(cHL)是一种起源于生发中心B细胞的淋巴恶性肿瘤,主要影响年轻成年人。临床特征、组织学亚型和免疫组化(IHC)模式在cHL的诊断和预后预测中起着关键作用。本研究基于十年来收集的大规模数据,考察了印度尼西亚雅加达西托·曼古库苏莫医院cHL的患病率、临床病理特征和IHC模式。方法 这项回顾性分析纳入了2014年至2023年确诊的739例cHL病例,通过苏木精和伊红染色以及免疫组化检测板进行鉴定。从病历中收集患者人口统计学、肿瘤位置和分期的数据。所使用的免疫组化标志物为CD20、CD3、CD30、CD15、PAX5、MUM1、Ki67和CD45。采用卡方检验和Fisher精确检验分析不同年龄组和分期的亚型分布。结果 受影响最严重的年龄组为20 - 29岁,共239例(32.34%),男性占优势,为396例(53.59%)。大多数肿瘤位于淋巴结区域,占532例(84.31%),而99例(15.69%)位于结外部位,主要在纵隔。结节硬化(NS)亚型最为常见,占461例(62.38%),其次是混合细胞型、淋巴细胞消减型和富于淋巴细胞型经典型霍奇金淋巴瘤。大多数病例在早期(I - III期)被诊断,NS与早期诊断显著相关(比值比3.06,95%置信区间(CI)1.30 - 7.22)。结论 我们研究中HL在患病率、年龄、性别和分期方面的发生情况与其他亚洲国家相似。观察到HL亚型与年龄和分期之间存在显著相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/20bf38317c00/cureus-0016-00000073482-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/1a5d3ae59355/cureus-0016-00000073482-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/f6148b6d1f2b/cureus-0016-00000073482-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/20bf38317c00/cureus-0016-00000073482-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/1a5d3ae59355/cureus-0016-00000073482-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/f6148b6d1f2b/cureus-0016-00000073482-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f540/11634568/20bf38317c00/cureus-0016-00000073482-i03.jpg

相似文献

1
A Decade of Prevalence and Clinicopathological Insights Into Classical Hodgkin Lymphoma: A Study From an Indonesian Tertiary Hospital.对经典型霍奇金淋巴瘤患病率及临床病理特征的十年洞察:来自印度尼西亚一家三级医院的研究
Cureus. 2024 Nov 11;16(11):e73482. doi: 10.7759/cureus.73482. eCollection 2024 Nov.
2
Hodgkin lymphoma: A clinicopathological and immunophenotypic study.霍奇金淋巴瘤:一项临床病理与免疫表型研究。
Indian J Med Paediatr Oncol. 2016 Jan-Mar;37(1):59-65. doi: 10.4103/0971-5851.177038.
3
Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.经典型霍奇金淋巴瘤,淋巴细胞消减型:临床病理分析及与其他经典型霍奇金淋巴瘤类型的预后比较。
Pathol Res Pract. 2013 Apr;209(4):201-7. doi: 10.1016/j.prp.2012.11.003. Epub 2013 Mar 9.
4
[Clinicopathologic features and association with Epstein-Barr virus infection in 235 cases of Hodgkin lymphoma from northern China].[中国北方235例霍奇金淋巴瘤的临床病理特征及与EB病毒感染的关系]
Zhonghua Bing Li Xue Za Zhi. 2015 Feb;44(2):84-9.
5
Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals.爱泼斯坦-巴尔病毒在阿联酋国民群体霍奇金淋巴瘤中的表达
Leuk Lymphoma. 2008 Sep;49(9):1769-77. doi: 10.1080/10428190802270894.
6
[Clinicopathologic study of 40 cases of mediastinal tumours of haematopoietic and lymphoid tissues].40例造血与淋巴组织纵隔肿瘤的临床病理研究
Zhonghua Bing Li Xue Za Zhi. 2012 Jun;41(6):376-81. doi: 10.3760/cma.j.issn.0529-5807.2012.06.004.
7
Expression Patterns of GATA3 in Classical Hodgkin Lymphoma: A Clinico-Pathological Study.GATA3在经典型霍奇金淋巴瘤中的表达模式:一项临床病理研究
Diseases. 2024 Feb 29;12(3):51. doi: 10.3390/diseases12030051.
8
Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.爱泼斯坦-巴尔病毒阳性结节性淋巴细胞为主型霍奇金淋巴瘤
Ann Diagn Pathol. 2014 Aug;18(4):203-9. doi: 10.1016/j.anndiagpath.2014.03.007. Epub 2014 Apr 13.
9
Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.皮肤 CD30 阳性 T 细胞淋巴瘤累及淋巴结,类似于经典霍奇金淋巴瘤。
Am J Surg Pathol. 2012 May;36(5):716-25. doi: 10.1097/PAS.0b013e3182487158.
10
Prevalence of Common Non-Hodgkin Lymphomas and Subtypes of Hodgkin Lymphoma by Nodal Site of Involvement: A Systematic Retrospective Review of 938 Cases.按受累淋巴结部位划分的常见非霍奇金淋巴瘤及霍奇金淋巴瘤亚型的患病率:938例病例的系统回顾性研究
Medicine (Baltimore). 2015 Jun;94(25):e987. doi: 10.1097/MD.0000000000000987.

本文引用的文献

1
Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.通过控制低表达来优化霍奇金淋巴瘤中 CD30 表达的评估。
Histol Histopathol. 2024 Mar;39(3):319-331. doi: 10.14670/HH-18-644. Epub 2023 Jun 21.
2
Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma.组织学亚型决定经典型霍奇金淋巴瘤独特的预后免疫特征。
Cancers (Basel). 2022 Oct 6;14(19):4893. doi: 10.3390/cancers14194893.
3
CD20 expression is closely associated with Epstein-Barr virus infection and an inferior survival in nodular sclerosis classical Hodgkin lymphoma.
CD20表达与爱泼斯坦-巴尔病毒感染以及结节硬化型经典霍奇金淋巴瘤患者较差的生存率密切相关。
Front Oncol. 2022 Sep 6;12:993768. doi: 10.3389/fonc.2022.993768. eCollection 2022.
4
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes.意大利、以色列和西班牙IIB期至IV期经典型霍奇金淋巴瘤的一线治疗:患者特征、治疗模式及临床结局
EJHaem. 2022 Apr 19;3(2):415-425. doi: 10.1002/jha2.426. eCollection 2022 May.
5
An Update on the Pathology and Molecular Features of Hodgkin Lymphoma.霍奇金淋巴瘤的病理学与分子特征更新
Cancers (Basel). 2022 May 26;14(11):2647. doi: 10.3390/cancers14112647.
6
Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis.霍奇金淋巴瘤的发病率、死亡率、危险因素和趋势:全球数据分析。
J Hematol Oncol. 2022 May 11;15(1):57. doi: 10.1186/s13045-022-01281-9.
7
Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India.霍奇金淋巴瘤的真实世界结局:来自印度的多中心注册研究
Front Oncol. 2022 Feb 11;11:799948. doi: 10.3389/fonc.2021.799948. eCollection 2021.
8
Global patterns of Hodgkin lymphoma incidence and mortality in 2020 and a prediction of the future burden in 2040.2020 年霍奇金淋巴瘤发病率和死亡率的全球模式及 2040 年未来负担的预测。
Int J Cancer. 2022 Jun 15;150(12):1941-1947. doi: 10.1002/ijc.33948. Epub 2022 Feb 7.
9
Elderly Hodgkin's lymphoma-a 10-year single-center experience.老年霍奇金淋巴瘤——一项为期10年的单中心经验
Ir J Med Sci. 2021 Aug;190(3):1239-1241. doi: 10.1007/s11845-020-02418-w. Epub 2020 Oct 28.
10
Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study.全球、区域和国家霍奇金淋巴瘤负担:2017 年全球疾病负担研究估计。
J Hematol Oncol. 2019 Oct 22;12(1):107. doi: 10.1186/s13045-019-0799-1.